Skip to main content

Articles

Retevmo Receives New FDA Indication for Advanced Solid Tumors with RET Fusion

Imbruvica Now Also Indicated for Children with Chronic Graft-versus-Host Disease

Pemazyre Receives New Indication for FGFR1-Positive Myeloid/Lymphoid Neoplasms

Vegzelma a New Biosimilar FDA Approved for the Treatment of 6 Types of Cancer

Enhertu First FDA-Approved Drug for HER2-Positive Non–Small-Cell Lung Cancer

Enhertu First FDA-Approved Treatment for HER2-Low Breast Cancer

Lytgobi FDA Approved for Intrahepatic Cholangiocarcinoma with FGFR2 Fusion

The Role of Non-Statin Lipid-Lowering Therapy in Older Adults with ASCVD

Interview with the Innovators

A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer

Conference Highlights ASCO

Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer

Page 13 of 244
Results 121 - 130 of 2440